Owners, management and financials
CVR: 28305087
Secondary names: GENIEMATICS A/S, Exiqon A/S
Previous names: GENIEMATICS A/S, CLC BIO A/S
DKK 83,701,000
Gross profit
Net result: DKK 4,914,000
Qiagen N.v. (100%)
CVR · view owners
Jonas Buur Sinding, Timothy Paul Grabham
Board: Axel Backheuer (chair) and 4 members
CVR · view management
Active
Founded 22 December 2004
CVR · view overview
106 employees
CVR · 2018
Director registered: Jonas Buur Sinding
CVR · 12/08/2026
View the full event history
QIAGEN AARHUS A/S is a Danish company of the type Aktieselskab based in Aarhus C, founded in 2004. The company is registered under the industry Computerprogrammering. The company was previously named CLC BIO A/S and GENIEMATICS A/S. The management consists of Jonas Buur Sinding and Timothy Paul Grabham. The board consists of Axel Backheuer (chair), Magnus Fellenius-Blædel, Martin Kofod Ludvigsen and Philipp Sixt Lothar von Hugo. The company is owned by Qiagen N.v.. The company has 106 employees (2018). In 2025, the company reported a gross profit of DKK 83,701,000 and a net result of DKK 4,914,000 compared with DKK 5,867,000 the year before. Equity in the 2025 report amounted to DKK 76,212,000.
Source: annual report 2025, Danish Business Authority
The financial health of QIAGEN AARHUS A/S appears to be improving, as evidenced by a consistent increase in gross profit from 46.36 million DKK in 2021 to 83.70 million DKK in 2025. Profitability has fluctuated, with a notable dip to a loss of 17.24 million DKK in 2021, but rebounded to a profit of 4.91 million DKK in 2025. The company's equity has also shown a positive trend, rising from 33.80 million DKK in 2021 to 76.21 million DKK in 2025, indicating a strengthening financial position. However, the absence of disclosed revenue figures raises concerns about transparency and overall market performance within the computer programming industry.
AI-generated summary · Generated 15/08/2026
Selskabets formål er udvikling og salg af software, konsulentydelser og undervisning, samt dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 83.7 mio. | 4.9 mio. | 92.6 mio. | 76.2 mio. | 60 | |
| 202401/01/2024 – 31/12/2024 | 67.6 mio. | 5.9 mio. | 91.9 mio. | 71.3 mio. | 61 | |
| 202301/01/2023 – 31/12/2023 | 56.3 mio. | 5.5 mio. | 101 mio. | 65.4 mio. | 66 | |
| 202201/01/2022 – 31/12/2022 | 56 mio. | 26.2 mio. | 247 mio. | 60 mio. | 67 | |
| 202101/01/2021 – 31/12/2021 | 46.4 mio. | -17.2 mio. | 289.1 mio. | 33.8 mio. | 68 | |
| 202001/01/2020 – 31/12/2020 | 39.5 mio. | -35.3 mio. | 369.6 mio. | 51 mio. | 74 | |
| 201901/01/2019 – 31/12/2019 | 39.8 mio. | -37.8 mio. | 374.7 mio. | 86.3 mio. | 98 | |
| 201801/01/2018 – 31/12/2018 | 42.2 mio. | -47.4 mio. | 532.9 mio. | 498.2 mio. | 102 | |
| 201701/01/2017 – 31/12/2017 | 57.1 mio. | -12.5 mio. | 106.1 mio. | 13.9 mio. | 93 | |
| 201601/01/2016 – 31/12/2016 | 48.5 mio. | -77.8 mio. | 104.6 mio. | -53.6 mio. | 100 | |
| 201501/01/2015 – 31/12/2015 | 70.9 mio. | 21.7 mio. | 133.8 mio. | 24.2 mio. | - | |
| 201201/01/2012 – 31/12/2012 | 30 mio. | 938 t. | 71.9 mio. | 21.9 mio. | 87 |
Compared to 4.558 companies in Computerprogrammering
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of QIAGEN AARHUS A/S is 28305087.
QIAGEN AARHUS A/S is owned by Qiagen N.v..
The management of QIAGEN AARHUS A/S consists of Jonas Buur Sinding and Timothy Paul Grabham.
The board of QIAGEN AARHUS A/S consists of Axel Backheuer, Magnus Fellenius-Blædel and Martin Kofod Ludvigsen, with Axel Backheuer as chair.
In 2025, QIAGEN AARHUS A/S reported a gross profit of DKK 83,701,000.
QIAGEN AARHUS A/S had 106 employees in 2018 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
As of August 12, 2026, Jonas Buur Sinding is registered as director of QIAGEN AARHUS A/S.
As of August 12, 2026, Lea Vinther Thøgersen has stepped down as director of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2025. Gross profit came to DKK 83,701,000, and the net result was DKK 4,914,000.
As of November 14, 2025, Magnus Fellenius-Blædel has joined the board of directors of QIAGEN AARHUS A/S.
As of November 14, 2025, Paula Cristina Tataru has left the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2024. Gross profit came to DKK 67,619,000, and the net result was DKK 5,867,000.
QIAGEN AARHUS A/S has published its annual report for 2023. Gross profit came to DKK 56,309,000, and the net result was DKK 5,453,000.
As of July 8, 2024, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of QIAGEN AARHUS A/S.
As of July 8, 2024, KPMG P/S has stepped down as auditor of QIAGEN AARHUS A/S.
As of November 13, 2023, Lea Vinther Thøgersen is registered as director of QIAGEN AARHUS A/S.
As of November 13, 2023, Henrik Sandmann has stepped down as director of QIAGEN AARHUS A/S.
As of October 6, 2023, Paula Cristina Tataru has joined the board of directors of QIAGEN AARHUS A/S.
As of October 6, 2023, Katja Einer-Jensen has left the board of directors of QIAGEN AARHUS A/S.
As of October 5, 2023, Paula Cristina Tataru has left the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2022. Gross profit came to DKK 55,964,000, and the net result was DKK 26,180,000.
As of December 22, 2022, Vivi Raundahl Gregersen has left the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2021. Gross profit came to DKK 46,362,000, and the net result was DKK -17,235,000.
As of October 5, 2021, Vivi Raundahl Gregersen has joined the board of directors of QIAGEN AARHUS A/S.
As of October 5, 2021, Katja Einer-Jensen has joined the board of directors of QIAGEN AARHUS A/S.
As of October 5, 2021, Paula Cristina Tataru has joined the board of directors of QIAGEN AARHUS A/S.
As of October 5, 2021, Jens-Uwe Schultz Appelt has left the board of directors of QIAGEN AARHUS A/S.
As of October 4, 2021, Katja Einer-Jensen has left the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2020. Gross profit came to DKK 39,485,000, and the net result was DKK -35,295,000.
As of July 5, 2021, Henrik Sandmann is registered as director of QIAGEN AARHUS A/S.
As of July 5, 2021, Jonathan Gary Sheldon has stepped down as director of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2019. Gross profit came to DKK 39,815,000, and the net result was DKK -37,840,000.
As of December 1, 2019, Daniel Christian Skov has left the board of directors of QIAGEN AARHUS A/S.
As of November 26, 2019, Axel Backheuer has joined the board of directors of QIAGEN AARHUS A/S.
As of November 26, 2019, Peer Michael Schatz has left the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2018. Gross profit came to DKK 42,176,000, and the net result was DKK -47,390,000.
QIAGEN AARHUS A/S has published its annual report for 2017. Gross profit came to DKK 57,079,000, and the net result was DKK -12,525,000.
As of February 1, 2018, Jonathan Gary Sheldon is registered as director of QIAGEN AARHUS A/S.
As of February 1, 2018, Laura Eldridge Furmanski has stepped down as director of QIAGEN AARHUS A/S.
As of August 18, 2017, Martin Kofod Ludvigsen has joined the board of directors of QIAGEN AARHUS A/S.
As of August 18, 2017, Katja Einer-Jensen has joined the board of directors of QIAGEN AARHUS A/S.
As of August 18, 2017, Jens-Uwe Schultz Appelt has joined the board of directors of QIAGEN AARHUS A/S.
As of August 18, 2017, Daniel Christian Skov has joined the board of directors of QIAGEN AARHUS A/S.
As of August 18, 2017, Mikael Christian Varrild Flensborg has left the board of directors of QIAGEN AARHUS A/S.
As of August 18, 2017, Anika Jöcker has left the board of directors of QIAGEN AARHUS A/S.
As of August 18, 2017, Jacob de Meza has left the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2016. Gross profit came to DKK 48,546,000, and the net result was DKK -77,775,000.
As of December 1, 2016, Jacob de Meza has joined the board of directors of QIAGEN AARHUS A/S.
As of November 30, 2016, Jacob Grydholt Jensen has left the board of directors of QIAGEN AARHUS A/S.
As of November 30, 2016, Jacob de Meza has left the board of directors of QIAGEN AARHUS A/S.
As of October 11, 2016, Laura Eldridge Furmanski is registered as director of QIAGEN AARHUS A/S.
As of October 11, 2016, Timothy Paul Grabham is registered as director of QIAGEN AARHUS A/S.
As of October 11, 2016, Kenneth Graabek Johansen has stepped down as director of QIAGEN AARHUS A/S.
As of October 11, 2016, Roald Forsberg has stepped down as director of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2015. Gross profit came to DKK 70,853,000, and the net result was DKK 21,722,000.
QIAGEN AARHUS A/S has published its annual report for 2014.
As of December 19, 2014, KPMG P/S has been appointed auditor of QIAGEN AARHUS A/S.
As of December 19, 2014, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of QIAGEN AARHUS A/S.
As of December 5, 2014, Dietrich Karl Hauffe has left the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2013.
As of May 27, 2014, Kenneth Graabek Johansen is registered as director of QIAGEN AARHUS A/S.
As of May 27, 2014, Roald Forsberg is registered as director of QIAGEN AARHUS A/S.
As of May 27, 2014, Thomas Knudsen has stepped down as director of QIAGEN AARHUS A/S.
On January 27, 2014, the company changed its name from CLC BIO A/S to QIAGEN AARHUS A/S.
As of August 22, 2013, Philipp Sixt Lothar von Hugo has joined the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Peer Michael Schatz has joined the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Roland Sackers has joined the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Dietrich Karl Hauffe has joined the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Jeppe Øvli Øvlesen has left the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Carsten Kultoft Lorentsen has left the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Jørn Kildegaard Andersen has left the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Kenneth Aaby Sachse has left the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, Finn Dueholm Støy has left the board of directors of QIAGEN AARHUS A/S.
As of August 22, 2013, is registered as an owner of QIAGEN AARHUS A/S with an ownership share of 100%.
As of June 27, 2013, Mikael Christian Varrild Flensborg has joined the board of directors of QIAGEN AARHUS A/S.
As of June 27, 2013, Anika Jöcker has joined the board of directors of QIAGEN AARHUS A/S.
As of June 27, 2013, Jacob Grydholt Jensen has joined the board of directors of QIAGEN AARHUS A/S.
As of June 27, 2013, Jacob de Meza has joined the board of directors of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S has published its annual report for 2012. Gross profit came to DKK 29,982,000, and the net result was DKK 938,000.
As of April 19, 2013, Jørn Kildegaard Andersen has joined the board of directors of QIAGEN AARHUS A/S.
As of April 19, 2013, Rasmus Sommerskov has left the board of directors of QIAGEN AARHUS A/S.
As of August 23, 2011, Rasmus Sommerskov has joined the board of directors of QIAGEN AARHUS A/S.
As of August 23, 2011, Niels Knudsen has left the board of directors of QIAGEN AARHUS A/S.
As of July 1, 2011, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of QIAGEN AARHUS A/S.
As of July 1, 2011, A/S PSE NR. 4820 has stepped down as auditor of QIAGEN AARHUS A/S.
As of September 1, 2009, Niels Knudsen has joined the board of directors of QIAGEN AARHUS A/S.
As of September 1, 2009, Bjarne Knudsen has left the board of directors of QIAGEN AARHUS A/S.
As of June 21, 2007, A/S PSE NR. 4820 has been appointed auditor of QIAGEN AARHUS A/S.
As of June 21, 2007, A/S PSE NR. 4820 has stepped down as auditor of QIAGEN AARHUS A/S.
As of June 21, 2007, Kenneth Aaby Sachse has joined the board of directors of QIAGEN AARHUS A/S.
As of March 15, 2005, Bjarne Knudsen has joined the board of directors of QIAGEN AARHUS A/S.
As of March 15, 2005, Thomas Knudsen has left the board of directors of QIAGEN AARHUS A/S.
On March 15, 2005, the company changed its name from GENIEMATICS A/S to CLC BIO A/S.
As of December 22, 2004, A/S PSE NR. 4820 has been appointed auditor of QIAGEN AARHUS A/S.
As of December 22, 2004, Jeppe Øvli Øvlesen has joined the board of directors of QIAGEN AARHUS A/S.
As of December 22, 2004, Carsten Kultoft Lorentsen has joined the board of directors of QIAGEN AARHUS A/S.
As of December 22, 2004, Thomas Knudsen has joined the board of directors of QIAGEN AARHUS A/S.
As of December 22, 2004, Finn Dueholm Støy has joined the board of directors of QIAGEN AARHUS A/S.
As of December 22, 2004, Thomas Knudsen is registered as director of QIAGEN AARHUS A/S.
QIAGEN AARHUS A/S was founded on December 22, 2004.
Companies in the same industry and area
CVR 45731170
CVR 25278216
CVR 46262018
CVR 44129477
CVR 31247179
